As per MRFR analysis, the US Mammography Market Size was estimated at 668.28 (USD Million) in 2023. The US Mammography Market Industry is expected to grow from 730.1 (USD Million) in 2024 to 1,800 (USD Million) by 2035. The US Mammography Market CAGR (growth rate) is expected to be around 8.549% during the forecast period (2025 - 2035).
The US mammography market is witnessing several important trends driven by advancements in technology, increasing awareness of breast cancer, and regulatory changes. A significant market driver is the rising incidence of breast cancer in the US, which has led to heightened screening initiatives and improved accessibility for women. Government programs and healthcare policies are actively promoting regular screenings, particularly in underserved communities. The introduction of digital mammography and tomosynthesis has enhanced diagnostic accuracy, making it easier for healthcare providers to detect abnormalities at earlier stages.
These technological advancements are increasingly being adopted across hospitals and outpatient facilities, creating a more efficient screening process. There are also valuable opportunities in the US mammography market with the push toward personalized healthcare. Patients are becoming more engaged in their health management, leading to a demand for tailored screening processes based on individual risk factors. This shift presents an opportunity for healthcare providers to develop patient-centered approaches, enhancing the overall experience while improving detection rates. Another opportunity lies in the integration of artificial intelligence (AI) into mammography.
AI-assisted readings can provide valuable support for radiologists, reducing workload and potentially improving outcomes. Recent trends include a growing emphasis on patient education and outreach programs aimed at increasing participation in routine screenings. Social media campaigns and community partnerships are expanding awareness around the importance of early detection, targeting diverse demographic groups to address disparities in breast cancer outcomes. As the healthcare landscape evolves, the US mammography market continues to adapt, focusing on innovation and improved patient outcomes.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The rising incidence of breast cancer is a significant driver for the US Mammography Market Industry. According to the American Cancer Society, it is estimated that around 268,600 new cases of invasive breast cancer will be diagnosed in women in the United States in 2021 alone. This alarming statistic highlights the need for enhanced screening, driving the demand for mammography services. The United States Preventive Services Task Force (USPSTF) recommends routine mammography screening starting at age 40, further influencing the market growth. As awareness surrounding breast cancer increases and more women seek early detection measures, the demand for mammography services is likely to grow, supporting the upward trajectory of the US Mammography Market Industry.
Technological advancements in mammography, such as the adoption of digital mammography systems and 3D tomosynthesis, significantly propel the US Mammography Market Industry forward. These innovations have improved the accuracy and reliability of breast cancer screenings, making it easier for radiologists to detect abnormalities. A report by the FDA noted that the use of digital systems has led to a decrease in false positives and improved the rate of cancer detection. As healthcare facilities in the United States increasingly adopt cutting-edge technologies to enhance patient outcomes, the demand for updated mammography equipment will inevitably rise, further driving the growth of the US Mammography Market Industry.
Government initiatives and funding to promote breast cancer awareness and screening programs significantly contribute to the growth of the US Mammography Market Industry. Programs funded by the Centers for Disease Control and Prevention (CDC) and the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) have increased access to mammography for underserved populations. The CDC's funding of approximately $213 million supports screening and diagnostic services for low-income women across the nation. Such initiatives not only foster awareness but also improve access to essential mammography services, making it a crucial driver for the US Mammography Market.
The growing population of aging women in the United States presents a favorable scenario for the US Mammography Market Industry. According to data from the United States Census Bureau, the female population aged 65 and older is projected to reach 29 million by 2030, representing a substantial increase from previous years. This demographic trend aligns with the higher incidence rates of breast cancer among older women, necessitating regular mammography screenings. As this population segment continues to grow, the demand for mammography services will likely increase, driving market growth and reinforcing the importance of the US Mammography Market Industry.
The US Mammography Market segmentation under the Type category showcases a critical distinction between Screening Mammography and Diagnostic Mammography, both of which play essential roles in breast cancer detection and management within the healthcare system. Screening Mammography serves as a preventive measure primarily aimed at women who do not exhibit symptoms of breast cancer, typically recommended for women aged 40 and above.
This segment is crucial for early detection since timely diagnosis can significantly increase survival rates and lead to less aggressive treatment options. Annual screening programs have been credited with reducing breast cancer mortality, thereby reflecting their importance in public health initiatives. The US has implemented various campaigns to promote regular screenings, fostering an environment that encourages women to utilize mammography services as part of their healthcare routine.
On the other hand, Diagnostic Mammography is utilized when breast abnormalities or symptoms such as lumps or discharge are present. This type of mammography is imperative for providing a more detailed examination of breast tissue and often involves further imaging procedures if abnormalities are detected. The ability to accurately diagnose potential issues using this modality is critical to guiding subsequent treatment and management strategies.
Moreover, as technological advancements continue to evolve within this sector, innovations such as 3D mammography have emerged, providing enhanced imaging capabilities that improve diagnosis accuracy, thereby solidifying the significance of this segment. Both segments significantly contribute to the US Mammography Market, driven by increasing breast cancer incidences and growing awareness of the importance of early detection.
The national push for preventive healthcare coupled with advances in imaging technologies and methodologies collectively propel market growth. However, challenges such as disparities in access to mammography services based on geographical location or socioeconomic status underscore the importance of addressing barriers to facilitate greater patient access to quality care. Overall, educating the population about the value of both Screening and Diagnostic Mammography will be vital as the market continues evolving, ensuring that effective solutions are readily available to address the pressing need for breast cancer detection and management nationwide.
Source: Primary Research, Secondary Research, MRFR Database and Analyst Review
The Technology segment of the US Mammography Market showcases significant evolution and development aimed at enhancing breast cancer detection and diagnosis. Among the various technologies available, 2-D Technology remains foundational and is widely utilized due to its established methodology and cost-effectiveness, allowing for vast accessibility in numerous healthcare settings. Conversely, 3-D Technology, also known as digital breast tomosynthesis, is gaining traction for its ability to provide more detailed images, reducing false-positive rates and allowing for earlier detection of anomalies.
This advancement is particularly vital as breast cancer statistics show that 1 in 8 women in the US will develop invasive breast cancer during their lifetime. Combination Technology incorporates both 2-D and 3-D imaging, offering clinicians a comprehensive view that supports accurate assessments; this hybrid approach is becoming increasingly popular due to its diagnostic accuracy. As advancements in mammography technology continue to develop, these methods are expected to play a pivotal role in improving patient outcomes and shaping future screening protocols in the US, driven by ongoing investment in Research and Development across the healthcare sector.
The US Mammography Market is witnessing significant advancements within its Product segment, encompassing a range of technologies essential for effective breast cancer screening and diagnosis. Digital Systems have transformed imaging practices, providing higher accuracy and faster results, which enhances patient outcomes. Analog Systems, while less prevalent, continue to serve important roles in certain facilities, demonstrating reliability in established practices.
Breast Tomosynthesis is gaining traction due to its ability to produce 3D images, thereby improving detection rates and minimizing false positives, making it a critical aspect of contemporary breast imaging solutions. Film Screen Systems still find applications, especially in facilities transitioning to more advanced technologies. The "Others" category encompasses emerging technologies and solutions that address specific needs in breast health.
The ongoing innovations and improvements within these segments are driven by the demand for early detection and the rising incidence of breast cancer in the US, making the US Mammography Market vital for public health initiatives. As the market continues to evolve, advancements across these diverse Product segments will play a key role in shaping the future landscape of mammography services.
The End-User segment in the US Mammography Market plays a crucial role in determining market dynamics and trends. Hospitals dominate this segment due to their extensive resources and capabilities to integrate advanced mammography systems, while Specialty Clinics focus on providing targeted breast health services, capitalizing on growing awareness among women. Research Institutes contribute significantly to innovation and the development of cutting-edge technologies, facilitating improved diagnostic accuracy.
Diagnostic Centers are vital as they offer comprehensive screening and detection services, attracting a significant number of patients for routine check-ups. The Other segment encompasses various healthcare providers that also cater to niche markets, thereby enhancing service accessibility. The increasing prevalence of breast cancer, along with initiatives aimed at raising awareness of regular screenings, is expected to drive demand across all components of this sector. Additionally, technological advancements and investments in healthcare infrastructure continue to bolster the US Mammography Market, positioning it for sustained growth in the coming years.
The US Mammography Market has witnessed significant advancements and competition, characterized by an array of innovative technologies and a growing focus on early detection of breast cancer. Companies in this sector are continually refining their imaging modalities, which includes digital mammography and 3D tomosynthesis, as well as supplementing their offerings with advanced artificial intelligence for improved accuracy in diagnosing conditions.
The competitive landscape is shaped by numerous vendors striving to enhance their market share through mergers and acquisitions, collaboration with healthcare institutions, and expanding their distribution networks to ensure broader access to their services. A deep understanding of the industry's regulatory environment coupled with consumer preferences and evolving healthcare policies shapes the strategic moves of players in this dynamic market.
Hologic is recognized as a prominent leader in the US Mammography Market, characterized by its unwavering commitment to women's health. The company specializes in developing and manufacturing state-of-the-art breast imaging equipment that allows for high-quality diagnostic outcomes, particularly through their advanced 3D Helical Mammography technology.
Hologic's strong presence in the US is bolstered by its focus on innovation and the development of products that integrate seamlessly into breast cancer screening programs. The company has established a reputation for not only producing reliable imaging systems but also for providing comprehensive support and training, which enhances the operational efficiency of healthcare providers. Strengthened by a robust portfolio of patents and a reputation for quality, Hologic maintains a competitive edge while advocating for improved standards in breast cancer detection and imaging technology.
Konica Minolta is a noteworthy player within the US Mammography Market, excelling in the realm of advanced imaging and diagnostic solutions. The company offers a suite of products, including digital mammography systems that prioritize patient comfort and high-resolution imaging for more accurate analyses. With a dedicated focus on innovation, Konica Minolta has carved out a strong niche in the market through its commitment to seamless integration of its technologies into existing healthcare systems.
Their strengths lie in developing user-friendly platforms that streamline workflows and enhance precision in diagnosis. The company's strategy is often complemented by strategic mergers and collaborations that extend their capabilities and market reach. These initiatives not only facilitate the introduction of cutting-edge technology but also solidify Konica Minolta's position as a significant contributor to early breast cancer detection solutions in the United States, indicating a thriving presence in this competitive landscape.
The US Mammography Market has seen significant developments recently, particularly with companies like Hologic, Siemens Healthineers, and Agfa Healthcare leading the way in advancing imaging technologies. In August 2023, Hologic announced new initiatives aimed at improving breast cancer detection rates through innovative mammography techniques and enhancements to their existing product lines. Meanwhile, Siemens Healthineers unveiled artificial intelligence-powered solutions designed to streamline mammography workflows, making them more efficient and accurate.
In terms of mergers and acquisitions, Konica Minolta acquired a predictive analytics firm in July 2023, enhancing its service offerings in imaging technology. Market valuations have increased, particularly due to high demand for early detection methods which are linked to rising breast cancer awareness. As of September 2023, Radiology Partners announced an expansion of its network, focusing on providing comprehensive radiology services amid a growing emphasis on preventive healthcare measures. Over the past few years, the trend towards integrating AI and machine learning in mammography has accelerated, particularly following regulatory approvals in early 2022, which has significantly impacted operational efficiencies and patient outcomes in the US healthcare landscape.
| Report Attribute/Metric Source: | Details |
| MARKET SIZE 2018 | 668.28(USD Million) |
| MARKET SIZE 2024 | 730.1(USD Million) |
| MARKET SIZE 2035 | 1800.0(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 8.549% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| MARKET FORECAST PERIOD | 2025 - 2035 |
| HISTORICAL DATA | 2019 - 2024 |
| MARKET FORECAST UNITS | USD Million |
| KEY COMPANIES PROFILED | Hologic, Konica Minolta, Agfa Healthcare, MRI Interventions, American Radiology Services, Radiology Partners, Fujifilm Medical Systems, Samsung Medison, RadNet, Elekta, Siemens Healthineers, Philips, Canon Medical Systems, General Electric, Carestream Health |
| SEGMENTS COVERED | Type, Technology, Product, End-User |
| KEY MARKET OPPORTUNITIES | Growing demand for digital mammography, Increasing awareness of breast cancer, Advancements in AI technology integration, Expanding breast screening programs, Rising popularity of home-based screening solutions |
| KEY MARKET DYNAMICS | rising cancer awareness, technological advancements, regulatory mandates, reimbursement policies, population aging |
| COUNTRIES COVERED | US |
Frequently Asked Questions (FAQ) :
The US Mammography Market is expected to be valued at 730.1 million USD in 2024.
By 2035, the US Mammography Market is projected to reach a value of 1800.0 million USD.
The US Mammography Market is anticipated to grow at a CAGR of 8.549% from 2025 to 2035.
The Screening Mammography segment is expected to dominate with a value of 400.0 million USD in 2024.
The Diagnostic Mammography segment is expected to be valued at 870.0 million USD by 2035.
Major players include Hologic, Siemens Healthineers, General Electric, and Fujifilm Medical Systems, among others.
The Screening Mammography segment is anticipated to have a value of 930.0 million USD in 2035.
The market is witnessing advancements in technology and increased awareness leading to enhanced opportunities.
Key players drive innovation and competition, significantly impacting market growth and consumer options.
The primary applications driving demand include screening and diagnostic procedures for breast cancer detection.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Analyst Explore the profile of garvit vyas, one of our esteemed authors at market research future, and access their expert research contributions in the field of market research and industry analysis
Get in Touch
© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
